SEC Form 4 · accession 0001209191-18-053446
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis Willard Sarena
Officer — Chief Strategy Officer
Period of report
Sep 28, 2018
Accepted (ET)
Oct 2, 2018 · 6:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 28, 2018 | A | 1,923 | $0.00 | A | 78,099 | D | |
| Common Stock | Sep 28, 2018 | F | 954 | $13.92 | D | 77,145 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock that were delivered to the reporting person on September 28, 2018 upon achievement of a performance-based condition applicable to a restricted stock award granted to the reporting person on February 7, 2017.
- F2Reflects a decrease of one share due to an adjustment to the rounding of the number of shares of restricted stock granted to the reporting person on February 7, 2017 and disclosed in the reporting person's Form 4 filed with the Securities and Exchange Commission on February 9, 2017.